{"hq_id":"hq-p-bdy-000135","name":"Pregnancy Skincare (Retinoid Teratogenicity, 'Pregnancy-Safe' Marketing)","category":{"primary":"personal_care","secondary":"skincare","tags":["pregnancy skincare","retinoid","retinol","vitamin A","teratogen","salicylic acid","pregnancy-safe"]},"product_tier":"BDY","overall_risk_level":"moderate","description":"Skincare products during pregnancy: retinoids (retinol, retinaldehyde, tretinoin, isotretinoin) are known teratogens — oral isotretinoin (Accutane) causes birth defects in 25-35% of exposed pregnancies. Topical retinol: FDA Category X for prescription retinoids. OTC retinol: limited systemic absorption, but dermatologists recommend avoidance during pregnancy (precautionary). Salicylic acid: topical low-concentration (≤2%) considered safe by ACOG; high-dose oral aspirin is not. 'Pregnancy-safe' is not an FDA-regulated term.","synthesis":{"derived_risk_level":"extreme","synthesis_confidence":0.85,"synthesis_method":"compound_composition","context_used":"human_pregnant","context_source":"product_users","exposure_modifier":1.208,"vulnerability_escalated":false,"escalation_reason":null,"compounds_resolved":1,"compounds_total":1,"synthesis_date":"2026-03-27","synthesis_version":"1.0.0"},"hazard_summary":{"sensitive_populations":"pregnant women (retinoid teratogenicity)","overall_risk":"moderate","primary_concerns":["Retinoids are known teratogens — oral isotretinoin causes 25-35% birth defect rate","Topical retinol: precautionary avoidance recommended during pregnancy","'Pregnancy-safe' is not FDA-regulated — no standard definition","Many women use retinol before pregnancy awareness (first trimester exposure)"],"exposure_routes":"Dermal absorption of topical skincare (limited systemic absorption)"},"exposure":{"routes":["dermal"],"contact_types":["skin_prolonged"],"users":["pregnant"],"duration":"hours","frequency":"daily","scenarios":["Daily retinol serum application during early pregnancy (before awareness)","Oral isotretinoin (Accutane): 25-35% birth defect rate — absolute contraindication","Topical salicylic acid ≤2%: considered safe by ACOG","'Pregnancy-safe' marketing: not FDA-regulated term"],"notes":"FDA Pregnancy Category X: isotretinoin (Accutane), tretinoin (Retin-A). iPLEDGE program: mandatory contraception during isotretinoin use. Topical retinol: minimal systemic absorption but recommended to stop during pregnancy (precautionary). Safe alternatives: vitamin C serum, niacinamide, hyaluronic acid, azelaic acid (FDA Category B). Dermatologist consultation recommended for pregnancy skincare routine."},"consumer_guidance":{"usage_warning":"STOP all retinoid products (retinol, retinaldehyde, tretinoin) when trying to conceive or upon pregnancy awareness. Isotretinoin: absolute contraindication — iPLEDGE program requires contraception. 'Pregnancy-safe' is marketing — consult dermatologist for evidence-based pregnancy skincare.","safer_alternatives":["Vitamin C serum (safe during pregnancy, antioxidant)","Niacinamide (safe, anti-inflammatory, brightening)","Hyaluronic acid (safe, hydration)","Azelaic acid (FDA Category B — safe for acne/pigmentation during pregnancy)"],"red_flags":[{"indicator":"Product not tested for or labeled for specific vulnerable population","meaning":"Standard safety data may not apply to your specific condition.","action":"Consult specialist physician for population-specific guidance."}],"green_flags":[{"indicator":"Physician-recommended or specifically tested for vulnerable population","meaning":"Safety evaluated for your specific condition/life stage.","verification":"Check for condition-specific certifications or physician guidance."}],"what_to_ask":[{"question":"Is this product safe for my specific health condition or life stage?","why_it_matters":"Safety varies dramatically by genetic background, life stage, and health condition.","good_answer":"Evaluated for your specific population with physician input.","bad_answer":"Generic safety data without population-specific consideration."}],"alternatives":[{"name":"Vitamin C serum","notes":"safe during pregnancy, antioxidant"},{"name":"Niacinamide","notes":"safe, anti-inflammatory, brightening"},{"name":"Hyaluronic acid","notes":"safe, hydration"}]},"regulatory":{"applicable_regulations":[{"jurisdiction":"USA","regulation":"FDA Pregnancy Category X (Retinoids)","citation":"21 CFR","requirements":"Isotretinoin, tretinoin: Category X (contraindicated). iPLEDGE program for isotretinoin. OTC retinol: no pregnancy labeling required.","compliance_status":null,"effective_date":null,"enforcing_agency":"FDA","penalties":null,"source_ref":null}],"certifications":[],"labeling":{"required_disclosures":[],"prop65_warning":{"required":null,"chemicals":[],"endpoint":null,"notes":null},"ghs_labeling":{"required":null,"signal_word":null,"pictograms":[],"hazard_statements":[],"notes":null},"hidden_ingredients":{"trade_secret_protected":null,"categories_hidden":[],"estimated_count":null,"known_concerns":null,"notes":null},"notes":null},"recalls":[],"regulatory_gap":null,"notes":null},"lifecycle":{"recyclable":true,"disposal_guidance":"Regular waste. Recycle container.","hazardous_waste":false,"expected_lifespan":"months"},"formulation":{"form":"varies","key_ingredients":[{"hq_id":"hq-c-org-000821","name":"Retinol (Vitamin A)","role":"teratogenic_concern","concentration_pct":"0.025-1"}],"certifications":[]},"materials":{"common":[],"concerning":[],"preferred":[]},"compound_composition":[{"hq_id":"hq-c-org-000821","compound_name":null,"role":"teratogenic_concern","typical_concentration":"0.025-1%"}],"identifiers":{"common_names":["pregnancy skincare (retinoid teratogenicity, 'pregnancy-safe' marketing)"],"aliases":[],"manufacturer":null,"brands":[]},"brand_examples":[{"brand":"Johnson & Johnson","manufacturer":"J&J","market_position":"mass_market","notable":"Broad personal care portfolio"},{"brand":"Unilever","manufacturer":"Unilever","market_position":"mass_market","notable":"Global personal care conglomerate"},{"brand":"Procter & Gamble","manufacturer":"P&G","market_position":"mass_market","notable":"Personal care market leader"}],"sources":[{"type":"expert_curation","name":"ALETHEIA Safety Database","date":"2026-03-25"},{"type":"regulation","title":"FDA Pregnancy Category X (Retinoids) (21 CFR)","jurisdiction":"USA","citation":"21 CFR","id":"src_61f4abda"},{"id":"src_001","type":"database","title":"PubChem Compound Database","year":2026,"inherited_from_compound":"hq-c-org-000821"},{"type":"regulatory","title":"US Food and Drug Administration (FDA)","jurisdiction":"USA","id":"src_82d1cfcd","extraction":"description_reference"}],"meta":{"schema_version":"4.0.0","last_updated":"2026-03-25","timestamp":"2026-05-02T15:24:22.653Z"}}